Abstract:Targeted protein degradation utilizing a bifunctional molecule to initiate ubiquitination and subsequent degradation by the 26S proteasome has been shown to be a powerful therapeutic intervention. Many bifunctional molecules, including covalent and non-covalent ligands to proteins of interest, have been developed. The traditional target protein degradation methodology targets the protein of interest in both healthy and diseased cell populations, and a therapeutic window is obtained based on the overexpression of the targeted protein. We report here a series of bifunctional degraders that do not rely on interacting with an E3 ligase, but rather a 26S proteasome subunit, which we have named ByeTACs: Bypassing E3 Targeting Chimeras. Rpn-13 is a non-essential ubiquitin receptor for the 26S proteasome. Cells under significant stress or require significant ubiquitin-dependent degradation of proteins for survival, incorporate Rpn-13 in the 26S to increase protein degradation rates. The targeted protein degraders reported here are bifunctional molecules that include a ligand to Rpn-13 and BRD4, the protein of interest we wish to degrade. We synthesized a suite of degraders with varying PEG chain lengths and showed that bifunctional molecules that incorporate a Rpn-13 binder (TCL1) and a BRD4 binder (JQ1) with a PEG linker of 3 or 4 units are the most effective to induce BRD4 degradation. We also demonstrate that our new targeted protein degraders are dependent upon proteasome activity and Rpn-13 expression levels. This establishes a new mechanism of action for our ByeTACs that can be employed for the targeted degradation of a wide variety of protein substrates.

Heterobifunctional molecules tackle targeted protein dephosphorylation

Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors

Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond

A covalent BTK ternary complex compatible with targeted protein degradation

Bifunctional modalities for repurposing protein function

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

Bivalent Ligands for Protein Degradation in Drug Discovery

EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling

Bifunctional Peptide Nanofibrils for Targeted Protein Degradation.

DNA framework-engineered chimeras platform enables selectively targeted protein degradation

A strategy to disentangle direct and indirect effects on (de)phosphorylation by chemical modulators of the phosphatase PP1 in complex cellular contexts

Controlling Kinase Activities by Selective Inhibition of Peptide Substrates

Targeted protein degradation: expanding the toolbox

Targeting phosphatases: From molecule design to clinical trials

PHOTACs enable optical control of protein degradation

ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation

Precise Modulation of Protein Degradation by Smart PROTACs

Applications of covalent chemistry in targeted protein degradation

Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras